BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11232330)

  • 1. Structure and mechanism in NF-kappa B/I kappa B signaling.
    Huxford T; Malek S; Ghosh G
    Cold Spring Harb Symp Quant Biol; 1999; 64():533-40. PubMed ID: 11232330
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal integration by transcription-factor assemblies: interactions of NF-AT1 and AP-1 on the IL-2 promoter.
    Chen L; Rao A; Harrison SC
    Cold Spring Harb Symp Quant Biol; 1999; 64():527-31. PubMed ID: 11232329
    [No Abstract]   [Full Text] [Related]  

  • 3. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of an IkappaBalpha/NF-kappaB complex.
    Jacobs MD; Harrison SC
    Cell; 1998 Dec; 95(6):749-58. PubMed ID: 9865693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of kappa B DNA binding by Rel/NF-kappa B dimers.
    Phelps CB; Sengchanthalangsy LL; Malek S; Ghosh G
    J Biol Chem; 2000 Aug; 275(32):24392-9. PubMed ID: 10825175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of Fc gamma R receptors induces monocyte chemoattractant protein-1 in the human monocytic cell line THP-1 by a mechanism involving I kappa B-alpha degradation and formation of p50/p65 NF-kappa B/Rel complexes.
    Alonso A; Bayón Y; Renedo M; Crespo MS
    Int Immunol; 2000 Apr; 12(4):547-54. PubMed ID: 10744656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
    Shumway SD; Miyamoto S
    Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal determinants of I kappa B alpha necessary for the cytoplasmic regulation of c-Rel.
    Luque I; Zong WX; Chen C; Gélinas C
    Oncogene; 2000 Feb; 19(9):1239-44. PubMed ID: 10713713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes.
    Tam WF; Wang W; Sen R
    Mol Cell Biol; 2001 Jul; 21(14):4837-46. PubMed ID: 11416157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2.
    Huang DB; Chen YQ; Ruetsche M; Phelps CB; Ghosh G
    Structure; 2001 Aug; 9(8):669-78. PubMed ID: 11587641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Verma IM; Stevenson JK; Schwarz EM; Van Antwerp D; Miyamoto S
    Genes Dev; 1995 Nov; 9(22):2723-35. PubMed ID: 7590248
    [No Abstract]   [Full Text] [Related]  

  • 13. A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.
    Sanjabi S; Williams KJ; Saccani S; Zhou L; Hoffmann A; Ghosh G; Gerondakis S; Natoli G; Smale ST
    Genes Dev; 2005 Sep; 19(18):2138-51. PubMed ID: 16166378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
    Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
    Phelps CB; Ghosh G
    Oncogene; 2004 Feb; 23(6):1229-38. PubMed ID: 14961076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
    Matthews JR; Watson E; Buckley S; Hay RT
    Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA recognition by NF kappa B and STAT transcription factors.
    Müller CW
    Ernst Schering Res Found Workshop; 2001; (34):143-66. PubMed ID: 11394043
    [No Abstract]   [Full Text] [Related]  

  • 18. Solvent exposed non-contacting amino acids play a critical role in NF-kappaB/IkappaBalpha complex formation.
    Huxford T; Mishler D; Phelps CB; Huang DB; Sengchanthalangsy LL; Reeves R; Hughes CA; Komives EA; Ghosh G
    J Mol Biol; 2002 Dec; 324(4):587-97. PubMed ID: 12460563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a non-alpha-helical DNA-binding motif in the Rel homology region.
    Liu J; Sodeoka M; Lane WS; Verdine GL
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):908-12. PubMed ID: 8302865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.
    Huxford T; Huang DB; Malek S; Ghosh G
    Cell; 1998 Dec; 95(6):759-70. PubMed ID: 9865694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.